Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Ampio and Daewoong enter urology drug agreement in South Korea

Sep. 15, 2011

Bayer discloses preclinical data on dual vasopressin V1A/V2 receptor antagonist

Sep. 8, 2011

Doxazosin versus tizanidine assessed in children with voiding dysfunction

Sep. 7, 2011

Randomized phase II trial evaluates alfuzosin in women with voiding dysfunction

Sep. 5, 2011

FDA accepts avanafil NDA

Sep. 2, 2011

LIST trial compares long-term effects of imidafenacin and solifenacin in OAB

Sep. 2, 2011

Phosphodiesterase 5 inhibitor suppresses bladder mechanosensory activity in vivo

Sep. 2, 2011

Clinical data presented on doxazosin/dutasteride in men with benign prostatic hyperplasia

Aug. 31, 2011

Astellas Pharma applies for approvals of mirabegron in U.S. and Europe

Aug. 29, 2011

FDA approves Botox for new indication

Aug. 25, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...